Synapse Medicine, a Bordeaux, France-based health tech startup, raised $28M in funding.
The round was led by Korelya Capital, with participation from XAnge, MACSF, and BNP Paribas Development.
The company, which has raised a total of $40m, intends to use the funds to accelerate the deployment of its medication reconciliation platform in the United States after already scaling across Europe and to expand its team in the US across pharmacists, sales, and marketing.
Led by CEO Dr Clement Goehrs, Synapse Medicine has developed a Medication Intelligence platform dedicated to proper drug use. With Synapse Platform, healthcare professionals can rely on medication reconciliation technology to prevent medication errors and improve patient safety. This streamlines the medication reconciliation process, allowing clinicians to manage treatments more efficiently at every care transition and improve coordination with stakeholders outside of the hospital.
The startup recently announced several partnerships with top hospitals, such as APHP–Paris (France), the largest hospital in Europe, ranked the eleventh best hospital worldwide, and German hospital La Charité, ranked in sixth place.
Dr Clement Goehrs will be moving to New York to scale US activities. The company will grow its workforce to 150 staff, with hirings planned in Paris, Bordeaux, Berlin, London, New York, and Tokyo.
FinSMEs
01/03/2022